MX9305713A - Restablecimiento de inmunocompetencia a celulas auxiliares t en pacientes infectados co hiv. - Google Patents
Restablecimiento de inmunocompetencia a celulas auxiliares t en pacientes infectados co hiv.Info
- Publication number
- MX9305713A MX9305713A MX9305713A MX9305713A MX9305713A MX 9305713 A MX9305713 A MX 9305713A MX 9305713 A MX9305713 A MX 9305713A MX 9305713 A MX9305713 A MX 9305713A MX 9305713 A MX9305713 A MX 9305713A
- Authority
- MX
- Mexico
- Prior art keywords
- immunocompetence
- hiv
- restoration
- patients infected
- auxiliary cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94731692A | 1992-09-18 | 1992-09-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9305713A true MX9305713A (es) | 1994-05-31 |
Family
ID=25485948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9305713A MX9305713A (es) | 1992-09-18 | 1993-09-17 | Restablecimiento de inmunocompetencia a celulas auxiliares t en pacientes infectados co hiv. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0667789A1 (fr) |
JP (1) | JPH08501549A (fr) |
AU (1) | AU4856793A (fr) |
CA (1) | CA2144648A1 (fr) |
MX (1) | MX9305713A (fr) |
WO (1) | WO1994006473A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19529026C2 (de) * | 1995-07-28 | 1997-06-19 | Robert Sabat | Monoklonale Antikörper gegen humanes Interleukin-10 |
WO1998010792A1 (fr) * | 1996-09-11 | 1998-03-19 | Prendergast Patrick T | Therapie a but immunitaire |
DE19939653A1 (de) * | 1999-08-13 | 2001-02-22 | Thomas Huenig | Verwendung CD28 spezifischer monoklonaler Antikörper zur Herstellung einer pharmazeutischen Zusammensetzung |
DE60138222D1 (de) | 2000-09-14 | 2009-05-14 | Beth Israel Hospital | Modulierung von il-2 und il-15 vermittelten t zellantworten |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL94878A (en) * | 1989-06-28 | 2003-01-12 | Schering Corp | Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
CZ281796B6 (cs) * | 1991-08-06 | 1997-02-12 | Schering Corporation | Použití interleukinu-10, jeho analoga, agonisty nebo antagonisty pro výrobu léčiva a farmaceutický přípravek je obsahující |
-
1993
- 1993-09-16 JP JP6508193A patent/JPH08501549A/ja active Pending
- 1993-09-16 AU AU48567/93A patent/AU4856793A/en not_active Abandoned
- 1993-09-16 WO PCT/US1993/008562 patent/WO1994006473A1/fr not_active Application Discontinuation
- 1993-09-16 CA CA002144648A patent/CA2144648A1/fr not_active Abandoned
- 1993-09-16 EP EP93921492A patent/EP0667789A1/fr not_active Withdrawn
- 1993-09-17 MX MX9305713A patent/MX9305713A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JPH08501549A (ja) | 1996-02-20 |
AU4856793A (en) | 1994-04-12 |
EP0667789A1 (fr) | 1995-08-23 |
WO1994006473A1 (fr) | 1994-03-31 |
CA2144648A1 (fr) | 1994-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2138086T3 (es) | Constructo de peptido sintetico compuesto que provoca anticuerpos neutralizantes y linfocitos t citotoxicos contra hiv. | |
MX9304837A (es) | Peptidos capaces de inhibir la actividad de proteasa vih, su preparacion y su uso terapeutico. | |
IT8603530A0 (it) | Membrana per uso farmaceutico ed industriale | |
ES2118835T3 (es) | 2-etil-1h-imidazo(4,5-c)quinolin-4-aminas antiviricas. | |
DE3751682D1 (de) | Infektiöses System zur Arzneimittelabgabe | |
ES2075050T3 (es) | Peptidos que tienen actividad cooperadora de celulas t. | |
AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
ES2172764T3 (es) | Modulacion de la expresion de citoquina th1/th2 por ribavirina en linfocitos t activados. | |
ES2051678T1 (es) | Derivados de 5-oxo-l-prolina y uso farmaceutico de los mismos. | |
ES2108969T3 (es) | Utilizacion de analogos de didesoxinucleosidos en el tratamiento de infecciones virales. | |
ES2167457T3 (es) | Nuevo uso medicinal de un antagonista de 5ht3. | |
ES2134197T3 (es) | Vacunas contra el virus del herpes simplex vp16. | |
CO4940406A1 (es) | Composiciones de paracetamol de accion rapida | |
MX9305713A (es) | Restablecimiento de inmunocompetencia a celulas auxiliares t en pacientes infectados co hiv. | |
MX9303572A (es) | Inhibidores de proteasa del sindrome de inmunodeficiencia humana, procedimiento para su preparacion y formualcion farmaceutica que los contiene. | |
IT1106143B (it) | Peptidi e loro derivati per uso farmaceutico e procedimento per la preparazione delle formulazioni che li contengono | |
ES2103493T3 (es) | Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo. | |
ES2111163T3 (es) | Uso de fosfonatos para el tratamiento de la osteoporosis. | |
UY27662A1 (es) | Inhibidores de la mocroglia para interrumpir reacciones inmunes asociadas con interleucina 12 y ifny. | |
ES2147453T3 (es) | Antagonistas de adenosina, procedimiento para su preparacion y su uso como medicamentos. | |
ES2137153T3 (es) | Uso de la prostaglandina e1 para curar la impotencia erectil masculina. | |
MX9307733A (es) | Restauracion de la funcion inmunologica en pacientes asintomaticos de vih-positivo. | |
ES2175661T3 (es) | Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
DK0614372T3 (da) | Antiviral faktor fra CD8+-celler | |
ES2131815T3 (es) | Diesteres de acido carbonico dotados de actividad antiviral y antiinflamatoria. |